Cancer drug price cuts take effect, set to save consumers ₹3,540 cr yearly
Revised Maximum Retail Prices (MRPs) of 1,364 anti-cancer formulations have come into effect from Monday, a move projected to save consumers an estimated Rs 3,540.38 crore annually, according to an official release. The National Pharmaceutical Pricing Authority (NPPA), functioning under the Department of Pharmaceuticals, capped trade margins on the MRP of 137 anti-cancer drugs based on…
Open True Mainstream to compare left, right, and center coverage